Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Cipla Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	500087
ISIN Demat	INE059A01026
Book Value	396.77

NSE Code	CIPLA
Dividend Yield %	1.06
Market Cap	1219638.82

P/E	23.65
EPS	63.86
Face Value	2


	BSE		NSE

25-Jun-2025

Last Price	1510.00
Net Change	7.15
% Change	0.48%
Prev.Close	1502.85
Open	1519.10
High	1519.10
Low	1500.00
Volume	15701

Last Price	1510.00
Net Change	7.6
% Change	0.51%
Prev.Close	1502.40
Open	1509.90
High	1518.00
Low	1500.00
Volume	1032762

Value	23679091
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	1519.10
52-Week High	1702.00
52-Week Low	1310.05

Value	1557652727.8
Best Buy	1510.00
Best Sell	0.00
Best Quantity	1527
Sell Quantity	0
Today's Range	1518.00
52-Week High	1702.05
52-Week Low	1335.00

Open Price	1517.20
High Price	1517.20
Low Price	1499.80
Last Price	1511.20
Prev Close	1505.40
Change	5.80
% Change	0.39 %

Average Price	1509.66
Underlying Value	1510.00
Number of contracts traded	12198
Turnover in Rs. Lakhs	59848
Open Interest	1845350.00
Change in O I	-2842450.00
% Change in O I	-60.64 %

Today

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	1527
Price	1510.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	1300
Price	1512.5

Quantity	325
Price	1513.9

Holding Details

Latest Corporate Events

Bonus

3 : 2

24-Apr-06

Book Closure

11-Aug-21

25-Aug-21

Dividend

150 %

27-Jun-25

Company News

31-05-2025

USFDA concludes cGMP insp...

30-05-2025

Cipla’s arm acquires 26% ...

30-05-2025

Cipla rises as its arm ac...

30-05-2025

Cipla’s arm incorporates ...

20-05-2025

Cipla’s arm inks pact to ...

19-05-2025

Cipla’s arm’s Mahape faci...

13-05-2025

Cipla reports 30% rise in...

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.